Suchergebnisse - "Dell'Aquila, Emanuela"

PubPharm (72)

1

Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients : A Multicenter Retrospective Analysis

enthalten in: Targeted oncology | 2024

von Basso, M. | Signorelli, C. | Calegari, M. | +17

2

Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer : A Real-World Subgroup Analysis

enthalten in: Cancers | 2023

von Signorelli, C. | Chilelli, M. | Giannarelli, D. | +22

3

Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis

enthalten in: Cancers | 2023

von Formica, V. | Morelli, C. | Conca, V. | +14

4

Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer : A Real-World Multicenter Retrospective Study

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Signorelli, C. | Calegari, M. | Basso, M. | +21

5

Acute left-sided malignant colonic obstruction : Is there a role for endoscopic stenting?

enthalten in: World journal of clinical oncology | 2023

von Russo, S. | Conigliaro, R. | Coppini, F. | +8

6

Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients

enthalten in: Frontiers in oncology | 2023

von Salvatore, L. | Bensi, M. | Vivolo, R. | +11

7

Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC) : A Pooled Analisys of Tribe and Tribe-2 Studies by GONO

enthalten in: Clinical colorectal cancer | 2022

von Dell'Aquila, E. | Rossini, D. | Galletti, A. | +17

8

Treatments after second progression in metastatic colorectal cancer : A pooled analysis of the TRIBE and TRIBE2 studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Rossini, D. | Germani, M. | Lonardi, S. | +15

9

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer : Data from the REVOLT study

enthalten in: Journal of geriatric oncology | 2022

von Rosati, G. | Corsi, D. | Avallone, A. | +11

10

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen : is there room for improvement?

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von Antonetti, P. | Fargnoli, M. | Porzio, G. | +27

1
2
3
4
5
6
7
8
Nächster »
[8]